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Salvia miltiorrhiza extract protects white
matter and the hippocampus from damage
induced by chronic cerebral hypoperfusion
in rats
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Abstract
Background: Salvia miltiorrhiza (SM), an herbal plant, is traditionally used in the treatment of cardiovascular and
cerebrovascular diseases in Asian countries. SM has multiple biological effects including anti-inflammatory activity.
The present study is aimed at investigating the effects of SM extract in rats with chronic cerebral hypoperfusion.
Methods: Chronic cerebral hypoperfusion was induced in male Wistar rats by permanent bilateral common carotid
artery occlusion (BCCAo). The rats were divided into 3 groups: sham-control, BCCAo treated with vehicle, and
BCCAo treated with SM extract. Vehicle or SM extract (200 mg/kg) were administered daily by oral gavage
beginning on day 21 after BCCAo and continuing to day 42. Immunohistochemical analyses were used to measure
Iba-1-positive microglia and myelin basic protein (MBP) in white matter and hippocampal tissue. In addition, the
expression levels of proinflammatory cytokines, including TNF-α, IL-1β, and IL-6, and the toll-like receptor (TLR)
pathway in the hippocampus, were analyzed by western blot.
Results: Administration of SM extract attenuated the activation of microglial cells in the white matter and
hippocampus after BCCAo. SM extract also prevented neuroinflammation after BCCAo by reducing hippocampal
levels of TNF-α, IL-1β, and IL-6, and increasing the reduced levels of MBP in the white matter and hippocampus.
Further, the administration of SM extract alleviated the up-regulation of hippocampal TLR4 and myeloid
differentiation primary response gene 88 (MyD88) in rats with chronic BCCAo.
Conclusions: Our findings suggest that SM may be a promising therapeutic candidate in vascular dementia
because of its protective effects against damage to the white matter and hippocampus after BCCAo.
Keywords: Salvia miltiorrhiza, Chronic cerebral hypoperfusion, Myelin basic protein, Toll-like receptor
Background
Vascular dementia (VaD), caused by changes in the
blood supply of the brain, is the second most common
form of dementia [1]. Neural dysfunction and cognitive
impairment occur in response to chronic cerebral hypo-
perfusion, which is observed in patients with VaD [2].
The effects of chronic cerebral hypoperfusion can be
studied in a widely accepted animal model using
permanent occlusion of the bilateral common carotid ar-
tery (BCCAo) in rats [3, 4]. BCCAo-induced damage to
white matter and the hippocampus has been reported in
many studies [5, 6]. The development of pathological
features is associated with the activation of inflammatory
cytokines such as interleukin-1 beta (IL-1β), IL-6, and
tumor necrosis factor alpha (TNF-α) [4, 7, 8]. Further-
more, the toll-like receptor (TLR) pathway has an im-
portant function during cerebral hypoperfusion as well
as mitogen-activated protein kinase (MAPK) signaling
[4, 7, 9, 10]. For example, TLR4-deficient mice are
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protected against the inflammatory response following
cerebral ischemia [11].
Salvia miltiorrhiza (Fam. Labiatae, SM), a traditional
herbal plant, is commonly used to treat the symptoms of
cardiovascular and cerebrovascular diseases in Korea,
China, Japan, and other Asian countries [12–15]. The
medium lethal dose of SM is 40–80 g/kg, which implies
that SM has low acute toxicity compared to the toxicity
of most of the other herbal medicines [16]. The benefi-
cial effects of SM have been demonstrated on ischemia-
induced symptoms including cellular damage and low
blood flow [14]. In addition, several research groups re-
ported the effects of SM on inflammatory responses.
Treatment of human vein endothelial cells with SM
caused a significant decrease of IL-6 and IL-8 [17]. Oral
gavage with polysaccharide from SM reduced TNF-α
and IL-1β levels in mouse models of liver injury [18].
Thus, SM has the potential to improve the pathology of
cerebrovascular diseases through anti-inflammatory
effects.
Although several studies revealed that SM has ef-
fects on cerebral ischemia including stroke, no study
regarding its potential impact on chronic cerebral hy-
poperfusion has been reported. Therefore, in order to
examine the effect of SM on damaged brain tissue fol-
lowing chronic cerebral hypoperfusion, SM extract
was administered by oral gavage to rats with BCCAo.
These animals were then examined to determine
whether SM extract treatments ameliorated BCCAo-
induced brain damage. Specifically, the effects of SM
extract on the activation of microglia and myelin in-
jury were examined in the white matter and hippo-
campus after chronic BCCAo. In addition, levels of
pro-inflammatory cytokines, and the expression of
proteins associated with the TLR pathway, were evalu-
ated in the hippocampus.
Methods
Animals
Forty-two 12-week-old male Wistar rats were used in
the chronic BCCAo experiments (Charles River Co.,
Gapyung, South Korea). For two weeks prior to begin-
ning the experiment, the rats were housed in a vivarium
at the Korea Institute of Oriental Medicine (KIOM)
under controlled temperature (22 ± 1 °C) and humidity
(55 ± 10 %) with a 12-h light/dark cycle. Food and water
were given ad libitum to all rats in this experiment. All
experimental procedures described in this report were
approved by the Institutional Animal Care and Use
Committee of the KIOM (permit number: 13–088).
Preparation of SM extracts
SM, produced in China, was obtained in 2011 from a
commercial supplier (Kwangmyung-Dang, Ulsan, Korea).
It was identified by the Herbal Quality Control Team
and deposited at the Creative Research Laboratory of
the KIOM. Dried SM was pulverized and extracted in
hot water for 3 h at room temperature by using an
ultrasound-assisted extractor (Daegu Haany University,
Daegu, Korea). The extract was filtered and then con-
centrated under vacuum using a rotary evaporator
(500 g, 33.2 % yield).
Ultra-performance liquid chromatography-quadrupole
time-of-flight mass spectrometry (UPLC-QTOF/MS) ana-
lyses of SM extracts
The constituents of the SM extract were analyzed and
identified by the UPLC-QTOF/MS technique (Figs. 1, 2
and Table 1). UPLC-QTOF/MS data were acquired from
an Acquity UPLC system (Waters Co., Milford, MA,
USA) that consisted of a binary solvent delivery system,
auto sampler, and photo diode array detector. A Waters
Aquity UPLC BEH C18 (150 mm × 2.1 mm, 1.7 μm)
Fig. 1 UPLC-DAD chromatogram of an SM extract. 1. Salvianic acid A; 2. protocatechuic aldehyde; 3. caffeic acid; 4. salvianolic acid G; 5. salvianolic
acid E/L; 6. rosmarinic acid; 7. salvianolic acid A; 8. salvianolic acid B; 9. salvianolic acid E/L
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column was used. The mobile phases were 20 mM for-
mic acid in H2O (A) and acetonitrile (B), with the fol-
lowing gradient (A to B): 5–11.5 % (0–3 min), 11.5–20 %
(3–3.1 min), 20–25 % (3.1-10 min), and 25–100 % (10–
14 min). The flow rate was set at 300 μL/min and the
injection volume was 2.0 μL. The temperatures of the
auto sampler and column oven were maintained at 15
and 40 °C, respectively. The chromatogram was re-
corded at 280 nm.
Mass spectrometry experiments were performed using
a Xevo G2 QTOF mass spectrometer (Waters MS Tech-
nologies, Manchester, UK), which was connected to the
UPLC system through an electrospray ionization inter-
face. Electrospray ionization conditions were set as fol-
lows: negative ion mode, capillary voltage, 2.5 kV’ cone
voltage, 40 V; source temperature, 120 °C; desolvation,
350 °C; cone gas flow, 50 L/h; and desolvation gas flow,
800 L/h. The ion acquisition rate was 0.2 s. Data were
Fig. 2 Chemical structures of constituents in the SM extract
Table 1 Chromatograms and high resolution mass data of constituents in the SM extract
Peak NO. Retention time (min) HR-mass [M-H]− Tolerance (ppm) λmax (nm) Formula Compound
1 2.13 197.0446 −2.0 200, 279 C9H10O5 Salvianic acid A
2 3.44 137.0238 −0.7 233, 279, 311 C7H6O3 Protocatechuic aldehyde
3 4.30 179.0335 −5.0 245, 325 C9H8O4 Caffeic acid
4 5.72 339.0489 −4.7 252, 286, 306 C18H12O7 Salvianolic acid G
5 6.18 717.1433 −3.2 247, 330 C36H30O16 Salvianolic acid E/L
6 6.65 359.0761 −1.7 244, 330 C18H16O8 Rosmarinic acid
7 6.78 493.1120 −3.0 253, 308 C26H22O10 Salvianolic acid A
8 7.63 717.1453 −0.4 228, 309 C36H30O16 Salvianolic acid B
9 8.80 717.1446 −0.7 253, 286, 306 C36H30O16 Salvianolic acid E/L
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centroided during acquisition using an independent
reference lock-mass ion via the LockSpray™ interface
to ensure accuracy and precision. Leucine encephalin
(m/z 554.2615 in negative mode) was used at 200 pg/μL
with an infusion flow rate of 5 μL/min.
HPLC analysis
The quantitation of major compound, salvianolic acid B,
in SM extract was performed by HPLC analysis. The
HPLC-DAD system consisting of a chromatographic
pump (P680, Dionex, Idstein, Germany), an automated
sample injector (ASI-100, Dionex), and a thermostatted
column compartment (TCC-100, Dionex) equipped with
an UVD 340U detector (Dionex). The chromatogram of
HPLC system was recorded by using Dionex’s Chrome-
leon™ Chromatography Data System. The column used
in this work was a Capcell Pak C-18 column (150 mm ×
4.6 mm, I.D., 5 μm, Shiseido Co., Ltd., Japan.). The col-
umn temperature was set to 30 °C. The mobile phase
consisted of (A) 0.1 % formic acid in water and (B)
100 % acetonitrile at a flow rate of 1.0 mL/min. The gra-
dient condition was as follows: 0–5 min, 10 %–30 % B;
5–25 min, 30 %–40 % B; 25–30 min, 40 %–100 % B.
Calibration curve and HPLC quantitation analysis
The calibration curve of salvianolic acid B (98 % purity,
Shanghai Sunny Biotech Co., Ltd., China) showed good
linearity (R2 = 0.9995) within the linear range (0.0125–
2 mg/mL) and the equation is y = 64.242x-0.2516 (y, peak
area; x, concentration of analyte). The sample solution
(10 mg/mL) was prepared for HPLC quantitation analysis.
The filtered solution of sample (10 μl) was injected into
the instrument. The sample was prepared in triplicate.
Peaks in the chromatograms were identified by comparing
the retention time and UV spectra with those of the stand-
ard. The content of analyte was calculated from calibra-
tion curve. The content of salvianolic acid B in SM extract
is 12.6 ± 0.03 mg/g drug.
Surgery and SM administration
Rats were anesthetized with 5 % isoflurane in a mixture
of 30 % oxygen/70 % nitrogen. BCCAo surgery was
modified based on previous reports [10, 19]. A midline
incision was performed to expose both common carotid
arteries that were then double-ligated tightly using silk
sutures 4–0. Control rats were subjected to a sham oper-
ation in which they underwent the same procedure with-
out BCCAo. During the surgical procedure, body
temperature was maintained at 37.0 ± 0.5 °C and all ef-
forts were made to minimize pain. We confirmed re-
duced glucose utilization following BCCAo which imply
established hypoperfusion (data not shown).
Rats were divided into three groups: a sham-operated
group with oral administration of saline (n = 12); a
BCCAo group with oral administration of saline (n = 15);
and a BCCAo group with oral administration of SM ex-
tract 200 mg/kg (n = 15). The dose of SM extract was
determined based on prescreening results. Oral gavage
treatments with saline or SM extract were initiated on
day 21 after BCCAo or sham surgery and continued
daily until day 42 (see Fig. 3). During the experiments,
two rats died in both the saline and the SM treatment
groups owing to stress related to surgery and long-term
oral feeding. The rats displayed no toxicity with respect
to changes in general behavior and mortality during the
oral treatments.
Western blot analyses
Tissue preparation and western blot were carried ac-
cording to a previously reported study with modifica-
tions [20]. Hippocampal tissue was homogenized in cold
RIPA buffer containing 25 mM Tris HCl pH 7.6,
150 mM NaCl, 1 % NP-40, 1 % sodium deoxycholate,
0.1 % SDS (Thermo Scientific, Waltham, MA, USA),
and protease and phosphatase inhibitor cocktail solution
(GenDEPOT, Barker, TX, USA), and centrifuged at
20,000 × g for 30 min at 4 °C. The supernatants were
harvested and stored at −70 °C. The protein concentra-
tion of each supernatant was determined using the BCA
assay (Thermo Scientific). Equal amounts of protein
(40 μg) were separated via SDS-PAGE and transferred to
a PVDF membrane that was incubated with a primary
antibody against TNF-α (Santa Cruz Biotechnologies,
Santa Cruz, CA, USA), IL-1β (Millipore Corporation,
Billerica, MA, USA), IL-6 (Abcam, San Francisco, CA,
USA), TLR4 (Santa Cruz), or myeloid differentiation
factor 88 (MyD88, Santa Cruz). Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH, Santa Cruz) was
used as the internal control. A goat anti-rabbit horserad-
ish peroxidase-conjugated secondary Ab (Cell Signaling,
Fig. 3 Experimental design
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Danvers, MA, USA) was then added and detection was
done using an ECL system (Thermo Scientific) with a
Lumino Image Analyzer (Las-4000; Fujifilm, Tokyo, Japan).
Densitometry was performed for specific markers normal-
ized to GAPDH using Multi Gauge software (Fujifilm).
Immunohistochemistry
Immunohistochemical analysis was performed as described
previously [3]. The brain was post-fixed in 4 % paraformal-
dehyde for 7 days, cryoprotected in phosphate-buffered sa-
line containing 30 % sucrose for 14 days at 4 °C, and then
stored at −70 °C. Cryosections of the brain (40 μm) were
incubated for 16 h at 4 °C with ionized calcium binding
adaptor molecule-1 (Iba-1, Wako, Tokyo, Japan), myelin
basic protein (MBP, Abcam), and NeuN (Millipore) in
phosphate buffered saline containing 3 % casein and 0.1 %
Triton-X 100, and then incubated with a goat anti-rabbit
antibody (Cell Signaling Technology). Finally, the stained
sections were treated with a Vector SG substrate kit and a
Vector DAB kit (Vector Laboratories, Burlingame, CA,
USA) for peroxidase-mediated staining, and mounted onto
resin-coated slides. The dried sections on the slides were
coverslipped using Permount reagent (Fisher Scientific,
Pittsburgh, PA, USA). The stained sections were examined
under light microscopy (Bx 51; Olympus, Japan) and the
number of Iba-1-positive microglial cells was assessed in
regions (0.03 mm2) of white matter (the corpus callosum,
fimbria, and optic tract) and the hippocampus (CA1, CA3,
and DG). The cell count data are presented as an average
of Iba-1 positive cell in each region. In addition, MBP level
was measured in the hippocampus, fornix, medial septum,
fimbria, and corpus callosum. The optical density of the
MBP was measured using Metamorph analysis software
(Molecular Devices, Sunnyvale, CA, USA). A minimum of
three different Iba-1- and MBP-stained sections per animal
were averaged for quantification.
Statistical analyses
Differences between groups were considered significant
at p < 0.05. One-way ANOVA with a post hoc test (Least
Significant Difference test) was performed to determine
the effects of SM extract administration on alterations in
the number of MBP and Iba-1-positive cells, as well as
the expression levels of TNF-α, IL-1β, IL-6, TLR4, and
MyD88 induced by chronic BCCAo. All data are pre-
sented as means ± standard deviation (S.D.).
Results
SM extract attenuated microglial proliferation in the
white matter and hippocampus of rats with chronic
BCCAo
Chronic cerebral hypoperfusion proliferates inflamma-
tory cells within the brain, including microglia [6, 21].
Therefore, to examine the effects of SM extract
treatment on neuroinflammation, the number of Iba-1-
positive microglia in the major regions of white matter
(corpus callosum, fimbria, and optic tract) and hippo-
campal formations (CA1, CA3, and DG) were measured
(Fig. 4a, b). ANOVA revealed significant group effects
of Iba-1 positive microglia in the corpus callosum, fim-
bria, optic tract, and hippocampal CA1 formation
(F(2,17) ≥ 7.263, p < 0.005). An ANOVA for the hippo-
campal CA3 and DG formations showed no group ef-
fects. Post-hoc analyses revealed that the number of
Iba-1-positive microglia in the vehicle-treated BCCAo
rats was significantly higher than the sham-control rats
in the corpus callosum, fimbria, optic tract, and hippo-
campal CA1 formation (Fig. 4c, d). The number of Iba-
1 positive microglia was less in the BCCAo rats treated
with SM extract than in the vehicle-treated BCCAo rats
in the above-mentioned areas (Fig. 4c, d).
Based upon NeuN immunostaining, no clear neuronal
cell death was observed in the hippocampal formation
after chronic BCCAo. Furthermore, the administration
of SM extract did not affect neuronal cell death (data
not shown). These results suggest that SM extract ad-
ministration mitigated chronic BCCAo-induced prolifer-
ation of microglia in the white matter and hippocampus.
SM extract attenuated the increased expression of
proinflammatory cytokines in the hippocampus of rats
with chronic BCCAo
Activated microglial cells release proinflammatory cyto-
kines [22]. To evaluate the effects of SM extract on the
up-regulated proinflammatory cytokines induced by
chronic BCCAo, western blotting was used to measure
hippocampal levels of TNF-α, IL-1β, and IL-6. ANOVA
showed significant group effects with all of these pro-
teins (F(2,15) ≥ 10.063, p < 0.005). Post-hoc analyses re-
vealed that chronic BCCAo increased the levels of these
cytokines in the hippocampus compared to sham-control
animals (Fig. 5). Increases in proinflammatory cytokines
by chronic BCCAo were not observed in the chronic
BCCAo rats treated with SM extract (Fig. 5). These results
indicate that SM extract administration yields improved
functional outcomes by reducing the proinflammatory cy-
tokines induced by chronic BCCAo.
SM extract up-regulated the reduced MBP in the white
matter and hippocampus after chronic BCCAo
In earlier studies, microglial cells were suggested to con-
tribute to myelin impairment through the activation of
proinflammatory cytokines including TNF-α [23, 24].
Disruption of myelinated fibers caused by chronic cere-
bral hypoperfusion has been also observed [7, 25, 26]. In
order to investigate the effects of SM extract on the
breakdown of myelin sheaths induced by chronic
BCCAo, MBP, a component of the myelin sheath, was
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measured in the hippocampus, fornix, medial septum,
fimbria, and corpus callosum. ANOVA revealed signifi-
cant group effects in the hippocampus, medial septum,
fimbria, and corpus callosum (F(2,17) ≥ 4.293, p < 0.05).
However, there were no group effects detected in the
fornix. Post-hoc analyses showed that the level of MBP
in the chronic BCCAo rats treated with vehicle was
significantly decreased in the hippocampus, fimbria, and
corpus callosum (Fig. 6). SM extract administration pre-
vented the loss of MBP following chronic BCCAo in the
hippocampus and fimbria (Fig. 6). These data indicate
that SM extract reversed the decrease in MBP in the
white matter and hippocampus caused by chronic
BCCAo.
Fig. 5 The effects of SM extract on proinflammatory cytokines in the hippocampus induced by chronic BCCAo. a Representative western blots of
TNF-α, IL-1β, and IL-6. b Levels of TNF-α, IL-1β, and IL-6 in the sham-control group (n = 6), BCCAo + vehicle group (n = 6), and BCCAo + SM group
(n = 6). Data are presented as means ± S.D. ##p < 0.01 compared with sham-control; *p < 0.05 and **p < 0.01 compared with BCCAo + vehicle
Fig. 4 The effects of SM extract on chronic BCCAo-induced microglial proliferation in white matter and the hippocampus. a Photomicrographs
illustrating Iba-1-positive cells in the corpus callosum, fimbria, and optic tract. b Photomicrographs illustrating Iba-1-positive cells in the hippocampal
subregions. c Quantitative analysis of the number of Iba-1-positive cells in the corpus callosum, fimbria, and optic tract. d Quantitative analysis
of the number of Iba-1-positive cells in the hippocampal subregions. Sham-control group (n = 6), BCCAo + vehicle group (n = 7), and BCCAo + SM
group (n = 7). Data are presented as means ± S.D. ##p < 0.01 compared with sham-control; *p < 0.05 and **p < 0.01 compared with BCCAo + vehicle.
Original magnification 40× for whole hippocampus and 200× for the other regions. Scale bar on entire hippocampus represents 250 μm and the other
subregions represent 50 μm
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SM extract mitigated activation of the TLR4 pathway in
the hippocampus after chronic BCCAo
Several studies have reported that glial cells express TLRs
and that their activation has detrimental effects in cerebral
ischemia [27–29]. Therefore, western blotting was used to
measure hippocampal levels of TLR2 and TLR4. ANOVA
showed significant group effects in TLR4 but not TLR2
expression (F(2,9) = 16.618, p < 0.001). Subsequent post-
hoc analyses revealed that the administration of SM ex-
tract decreased the increased TLR4 seen after chronic
BCCAo (Fig. 7a, b).
To determine whether the effects of chronic BCCAo
occurred through MyD88-dependent pathways, hippo-
campal levels of Toll/IL-1R domain–containing adaptor-
inducing IFN-β (TRIF), and MyD88, in the downstream
pathway of TLR4 [30], were measured. ANOVA revealed
significant group effects in MyD88 but not in TRIF ex-
pression (F(2,9) = 24.458, p < 0.001). This suggests that
SM extract regulates the MyD88-dependent TLR path-
way. Post-hoc analyses showed that SM extract admi-
nistration reduced the increase of MyD88 caused by
BCCAo (Fig. 7c, d). Taken together, these results suggest
that the administration of SM extract regulated changes
in the TLR4/MyD88 pathway caused by chronic BCCAo.
Discussion
SM, also known as “Danshen,” is a traditional Asian
medicine. It has been commonly used for the treatment
of cardiovascular and cerebrovascular diseases [12, 31,
32]. The biological effects of SM and its extract have
been clarified in the last 20 years, providing evidence for
anti-inflammatory [33], anti-proliferative [34], and anti-
apoptotic effects [35]. Safety monitoring of SM also has
been conducted. Treatment of patients with hyperten-
sion and diabetes with SM seems to have little effect on
the metabolism of lipids and glucose, blood pressure,
and heart rate [36, 37]. These results indicate that SM
could be a useful and safe natural drug candidate.
Chemical analysis of SM extract by UPLC showed that
it contains some phenolic compounds, such as rosmarinic
acid, caffeic acid, and salvianolic acid A and B [37, 38].
These phenolic acids may have antioxidant activity against
Fig. 6 The effects of SM extract on the chronic BCCAo-induced reduction of MBP in the white matter and hippocampus. a Photomicrographs of
MBP positive cells in the hippocampus, fornix, medial septum, fimbria, and corpus callosum. b Levels of MBP in the sham-control group (n = 6),
BCCAo + vehicle group (n = 7), and BCCAo + SM group (n = 7). MBP density is expressed as arbitrary units. Data are presented as means ± S.D.
#p < 0.05 and ##p < 0.01 compared with sham-control; *p < 0.05 and **p < 0.01 compared with BCCAo + vehicle. Original magnification 40× for
the hippocampus and 200× for the other regions. Scale bar on hippocampus, fornix, and medial septum represent 250 μm and fimbria and
corpus callosum represent 50 μm
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peroxidative damage. Traumatic brain injury induced in
mice leads to cognitive impairment and neuroinflamma-
tion. Treatment of these animals with salvianolic acid B,
one of the active constituents of SM, restored spatial
memory and inhibited the expression of proinflammatory
cytokines [39]. Other studies have revealed that salvianolic
acid B has antioxidant effects, protects against ischemia in
rats, and restores memory functions affected by cerebral
transient ischemia in mice [40, 41]. In addition, rosmarinic
acid, which is one of the bioactive compounds of Echium
amoneum, inhibits the expression of cyclooxygenase-2 in
transient BCCAo in rats [42]. Caffeic acid and its deriva-
tives found in Coriandrum sativum have antioxidant
properties following 30 min of BCCAo in rats [43, 44].
These results imply that these phenolic compounds could
provide protection against the chronic BCCAo that occurs
when cerebral blood flow is reduced, similar to transient
BCCAo. Accordingly, it is possible that SM exerts its
beneficial effects through the activity of its phenolic acid
constituents.
A large body of evidence indicates that SM can ameli-
orate brain injury. For example, intraperitoneal injec-
tion of SM in ischemia-reperfusion injured rats reduced
the region of cerebral infarction [45]. However, no pre-
vious study has examined the effect of SM on damage
to the white matter and hippocampus induced by
chronic cerebral hypoperfusion. The present study
explored the beneficial effect of SM extract on chronic
BCCAo.
Evidence indicates that the proliferation of glia, such as
astrocytes and microglia, occurred in response to both
transient and chronic cerebral hypoperfusion [46, 47]. In-
creased numbers of glial cells contribute to the release of
inflammatory cytokines that are capable of causing brain
damage [46]. Thus, inhibition of glial proliferation, and
consequently proinflammatory cytokines, may be critical
in recovering from chronic BCCAo.
We demonstrated previously that the chronic BCCAo
rat model is suitable for examining the effectiveness of
natural medicines for VaD [7, 10]. Daily treatment with
SM extract or vehicle was started 21 days after BCCAo
surgery based on the results of our previous report,
which showed that inflammatory molecules peaked at
this time [3]. The present study showed that SM extract
inhibited chronic BCCAo-induced microglia cell prolif-
eration in the white matter and hippocampus. Addition-
ally, down-regulation of increased hippocampal TNF-α,
IL-1β, and IL-6 was observed in the chronic BCCAo rats
treated with SM extract. These findings suggest that SM
may possess protective effects on chronic cerebral hypo-
perfusion via inhibition of the inflammatory response.
We also identified the effect of SM extract on the ex-
pression of MBP after BCCAo in the hippocampus and
white matter. MBP is associated with stabilization of the
Fig. 7 The effects of SM extract on TLR-related proteins in the hippocampus after chronic BCCAo. Representative western blots of (a) TLR2 and
TLR4, and (c) TRIF and MyD88. Levels of (b) TLR-related and (d) TRIF and MyD88 proteins in the sham-control group (n = 4), BCCAo + vehicle
group (n = 4), and BCCAo + SM group (n = 4). Data are presented as means ± S.D. ##p < 0.01 compared with sham-control; *p < 0.05 and **p < 0.01
compared with BCCAo + vehicle
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myelin sheath, a key element of white matter [26]. De-
myelination induced by chronic cerebral hypoperfusion
can damage not only white matter but also gray matter
including the hippocampus [48, 49]. Specifically, it has
been hypothesized that proinflammatory molecules re-
leased by microglia accelerate myelin degradation [24, 50].
Confirming previous reports [7], the expression of MBP
was down-regulated in response to chronic BCCAo in the
hippocampus and white matter. However, the decrease in
MBP was not observed in rats with chronic BCCAo given
SM extract. These findings suggest that SM may suppress
the breakdown of MBP following chronic cerebral hypo-
perfusion. In addition, these data imply that SM might be
beneficial in the treatment of other demyelinating diseases
including multiple sclerosis [51]. Further studies are
needed to determine the mechanisms underlying the ef-
fects of SM on myelin disruption.
TLR signaling plays a role in the immune response.
TLRs are expressed constitutively within glial cells [52].
Among TLRs, TLR4 recruits either MyD88 or TRIF after
endocytosis [30], and induces the production of cytokines
and chemokines [53]. Several studies using TLR knockout
mice, usually TLR4, demonstrate detrimental effects of
TLRs in cerebral ischemia [11, 54]. For example, TLR4-
deficient mice do not show increased inflammatory
responses compared to wild-type mice post-stroke [54].
The present study showed that SM extract inhibited the
up-regulation of hippocampal TLR4 and MyD88 post-
BCCAo. Therefore, our results indicate that SM adminis-
tration may provide protection against chronic cerebral
hypoperfusion via MyD88-dependent TLR4 pathways.
We have demonstrated that SM extract protects white
matter and hippocampal tissue from damage induced by
chronic cerebral hypoperfusion. This is the first report of
SM extract in models of chronic BCCAo. However, fur-
ther studies are needed to characterize the effects of phen-
olic compounds contained in SM extracts on chronic
BCCAo. In spite of several studies about the effect of con-
stituents of SM on learning and memory in dementia and
VaD model, few studies have been conducted to investi-
gate the effect of whole SM extract on learning and mem-
ory [41, 55]. Therefore, future studies should explore the
effects of SM extract on cognitive impairment, which is a
common event in patients with VaD.
Conclusions
In summary, the current study provides data demonstrat-
ing the protective effects of SM extract against chronic
BCCAo-induced VaD. SM extract decreased the prolifera-
tion of microglia and minimized the impairment of MBP
in the white matter and hippocampus after BCCAo. SM
extract administration also attenuated the release of proin-
flammatory cytokines and prevented alterations of TLR4
signaling in the hippocampus induced by chronic BCCAo.
Taken together, these findings suggest that SM is a poten-
tial therapeutic natural medicine for the treatment of VaD.
Competing interests
The authors declare that there is no conflict of interests.
Authors’ contributions
MSK and WKJ designed the study and wrote the manuscript. JHB, HWK and
SHS performed the experimentation. JL and JSH carried out the statistical
analysis and interpretation of data. All authors read and approved the final
manuscript.
Acknowledgments
This study was supported by a grant (KIOM-2010-2) from the Inter-
Institutional Collaboration Research Program under the Korea Research
Council of Fundamental Science & Technology. This study was also
supported in part by grants (K12220, K13220, and K15310) from the KIOM.
Author details
1Korea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Yuseong-gu,
Daejeon 305-811, Republic of Korea. 2Department of Internal Medicine,
School of Medicine, Keimyung University, 1095 Dalgubeoldae-ro, Dalseo-gu,
Daegu 704-701, Republic of Korea. 3College of Pharmacy and Institute of
Pharmaceutical Research, Seoul National University, 1 Gwanak-ro, Gwanak-gu,
Seoul 151-742, Republic of Korea. 4Department of Biological Sciences, Konkuk
University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of
Korea. 5Korean Medicine Life Science, University of Science & Technology,
Daejeon 34054, Republic of Korea.
Received: 28 June 2015 Accepted: 19 November 2015
References
1. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al.
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing
stroke and dementia. Nature. 1996;383(6602):707–10.
2. Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, da Costa MS, et al.
Chronic brain hypoperfusion causes early glial activation and neuronal
death, and subsequent long-term memory impairment. Brain Res Bull.
2012;87(1):109–16.
3. Bang J, Jeon WK, Lee IS, Han JS, Kim BY. Biphasic functional regulation in
hippocampus of rat with chronic cerebral hypoperfusion induced by
permanent occlusion of bilateral common carotid artery. PLoS One.
2013;8(7):e70093.
4. Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery
occlusion in the rat: a model for chronic cerebral hypoperfusion-related
neurodegenerative diseases. Brain Res Rev. 2007;54(1):162–80.
5. O'Sullivan M. Leukoaraiosis. Pract Neurol. 2008;8(1):26–38.
6. Cho KO, La HO, Cho YJ, Sung KW, Kim SY. Minocycline attenuates white
matter damage in a rat model of chronic cerebral hypoperfusion. J Neurosci
Res. 2006;83(2):285–91.
7. Lee KM, Bang JH, Han JS, Kim BY, Lee IS, Kang HW, et al. Cardiotonic pill
attenuates white matter and hippocampal damage via inhibiting microglial
activation and downregulating ERK and p38 MAPK signaling in chronic
cerebral hypoperfused rat. BMC Complement Altern Med. 2013;13:334.
8. Saito K, Suyama K, Nishida K, Sei Y, Basile AS. Early increases in TNF-alpha,
IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain.
Neurosci Lett. 1996;206(2–3):149–52.
9. Yang QW, Li JC, Lu FL, Wen AQ, Xiang J, Zhang LL, et al. Upregulated
expression of toll-like receptor 4 in monocytes correlates with severity of
acute cerebral infarction. J Cereb Blood Flow Metab. 2008;28(9):1588–96.
10. Jeon WK, Ma J, Choi BR, Han SH, Jin Q, Hwang BY, et al. Effects of Fructus
mume Extract on MAPK and NF-kappaB Signaling and the Resultant
Improvement in the Cognitive Deficits Induced by Chronic Cerebral
Hypoperfusion. Evid Based Complement Altern Med. 2012;2012:450838.
11. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. Toll-like
receptor 4 is involved in brain damage and inflammation after experimental
stroke. Circulation. 2007;115(12):1599–608.
12. Chen X, Guo J, Bao J, Lu J, Wang Y. The anticancer properties of Salvia
miltiorrhiza Bunge (Danshen): a systematic review. Med Res Rev.
2014;34(4):768–94.
Kim et al. BMC Complementary and Alternative Medicine  (2015) 15:415 Page 9 of 10
13. Chan TY. Interaction between warfarin and danshen (Salvia miltiorrhiza).
Ann Pharmacother. 2001;35(4):501–4.
14. Liu J, Shen HM, Ong CN. Salvia miltiorrhiza inhibits cell growth and induces
apoptosis in human hepatoma HepG(2) cells. Cancer Lett. 2000;153(1–2):85–93.
15. Ji XY, Tan BK, Zhu YZ. Salvia miltiorrhiza and ischemic diseases. Acta
Pharmacol Sin. 2000;21(12):1089–94.
16. Wang B-Q. Salvia miltiorrhiza: Chemical and pharmacological review of a
medicinal plant. J Med Plants Res. 2010;4(25):2813–20.
17. Stumpf C, Fan Q, Hintermann C, Raaz D, Kurfurst I, Losert S, et al. Anti-
inflammatory effects of danshen on human vascular endothelial cells in
culture. Am J Chin Med. 2013;41(5):1065–77.
18. Song YH, Liu Q, Lv ZP, Chen YY, Zhou YC, Sun XG. Protection of a
polysaccharide from Salvia miltiorrhiza, a Chinese medicinal herb, against
immunological liver injury in mice. Int J Biol Macromol. 2008;43(2):170–5.
19. Choi BR, Kwon KJ, Park SH, Jeon WK, Han SH, Kim HY, et al. Alternations of
Septal-hippocampal System in the Adult Wistar Rat with Spatial Memory
Impairments Induced by Chronic Cerebral Hypoperfusion. Exp Neurobiol.
2011;20(2):92–9.
20. Kim M-S, Jeon WK, Lee KW, Park YH, Han J-S. Ameliorating Effects of Ethanol
Extract of Fructus mume on Scopolamine-Induced Memory Impairment in
Mice. Evid Based Complement Altern Med. 2015;2015:102734.
21. Cai ZY, Yan Y, Chen R. Minocycline reduces astrocytic reactivation and
neuroinflammation in the hippocampus of a vascular cognitive impairment
rat model. Neurosci Bull. 2010;26(1):28–36.
22. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, et al. Ibuprofen
suppresses plaque pathology and inflammation in a mouse model for
Alzheimer’s disease. J Neurosci. 2000;20(15):5709–14.
23. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and
oligodendrocyte damage in vitro. Ann Neurol. 1988;23(4):339–46.
24. Wakita H, Tomimoto H, Akiguchi I, Lin JX, Ihara M, Ohtani R, et al. Ibudilast,
a phosphodiesterase inhibitor, protects against white matter damage under
chronic cerebral hypoperfusion in the rat. Brain Res. 2003;992(1):53–9.
25. Miki K, Ishibashi S, Sun L, Xu H, Ohashi W, Kuroiwa T, et al. Intensity of
chronic cerebral hypoperfusion determines white/gray matter injury and
cognitive/motor dysfunction in mice. J Neurosci Res. 2009;87(5):1270–81.
26. Kurumatani T, Kudo T, Ikura Y, Takeda M. White matter changes in the gerbil
brain under chronic cerebral hypoperfusion. Stroke. 1998;29(5):1058–62.
27. Olson JK, Miller SD. Microglia initiate central nervous system innate and
adaptive immune responses through multiple TLRs. J Immunol.
2004;173(6):3916–24.
28. Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V, et al. TLR2
has a detrimental role in mouse transient focal cerebral ischemia. Biochem
Biophys Res Commun. 2007;359(3):574–9.
29. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors
and differential regulation of Toll-like receptor mRNAs in leukocytes in
response to microbes, their products, and cytokines. J Immunol.
2002;168(2):554–61.
30. Tanimura N, Saitoh S, Matsumoto F, Akashi-Takamura S, Miyake K. Roles for
LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-
signaling. Biochem Biophys Res Commun. 2008;368(1):94–9.
31. Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A, et al.
Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza)
attenuates hypertrophy induced by angiotensin II in cultured neonatal rat
cardiac cells. Biochem Pharmacol. 2002;64(4):745–9.
32. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, et al. Ameliorating effects of
compounds derived from Salvia miltiorrhiza root extract on microcirculatory
disturbance and target organ injury by ischemia and reperfusion. Pharmacol
Ther. 2008;117(2):280–95.
33. Kang BY, Chung SW, Kim SH, Ryu SY, Kim TS. Inhibition of interleukin-12 and
interferon-gamma production in immune cells by tanshinones from Salvia
miltiorrhiza. Immunopharmacology. 2000;49(3):355–61.
34. Lin YL, Lee TF, Huang YJ, Huang YT. Antiproliferative effect of salvianolic
acid A on rat hepatic stellate cells. J Pharm Pharmacol. 2006;58(7):933–9.
35. Nakazawa T, Xui N, Hesong Z, Kinoshita M, Chiba T, Kaneko E, et al.
Danshen inhibits oxysterol-induced endothelial cell apoptosis in vivo.
J Atheroscler Thromb. 2005;12(3):132–7.
36. Woo KS, Yip TW, Chook P, Kwong SK, Szeto CC, Li JK, et al. Cardiovascular
Protective Effects of Adjunctive Alternative Medicine (Salvia miltiorrhiza and
Pueraria lobata) in High-Risk Hypertension. Evid Based Complement Altern
Med. 2013;2013:132912.
37. Qian Q, Qian S, Fan P, Huo D, Wang S. Effect of Salvia miltiorrhiza
hydrophilic extract on antioxidant enzymes in diabetic patients with chronic
heart disease: a randomized controlled trial. Phytother Res. 2012;26(1):60–6.
38. Shen J, Yang K, Sun C, Zheng M. Analysis of active components in Salvia
miltiorrhiza injection based on vascular endothelial cell protection. Acta
Pharma. 2014;64(3):325–34.
39. Chen T, Liu W, Chao X, Zhang L, Qu Y, Huo J, et al. Salvianolic acid B
attenuates brain damage and inflammation after traumatic brain injury in
mice. Brain Res Bull. 2011;84(2):163–8.
40. Chen YH, Du GH, Zhang JT. Salvianolic acid B protects brain against
injuries caused by ischemia-reperfusion in rats. Acta Pharmacol Sin.
2000;21(5):463–6.
41. Du GH, Qiu Y, Zhang JT. Salvianolic acid B protects the memory functions
against transient cerebral ischemia in mice. J Asian Nat Prod Res.
2000;2(2):145–52.
42. Safaeian L, Tameh A, Ghannadi A, Naghani E, Tavazoei H, Alavi S. Protective
effects of Echium amoenum Fisch. and CA Mey. against cerebral ischemia in
the rats. Adv Biomed Res. 2015;4(1):107.
43. Wangensteen H, Samuelsen AB, Malterud KE. Antioxidant activity in extracts
from coriander. Food Chem. 2004;88(2):293–7.
44. Vekaria RH, Patel MN, Bhalodiya PN, Patel V, Desai TR, Tirgar PR. Evaluation
of neuroprotective effect of Coriandrum sativum linn. against ischemic-
reperfusion insult in brain. Internatational J Phytopharmacology.
2012;3(2):186–93.
45. Lo CJ, Lin JG, Kuo JS, Chiang SY, Chen SC, Liao ET, et al. Effect of salvia
miltiorrhiza bunge on cerebral infarct in ischemia-reperfusion injured rats.
Am J Chin Med. 2003;31(2):191–200.
46. Cai M, Shin BY, Kim DH, Kim JM, Park SJ, Park CS, et al. Neuroprotective
effects of a traditional herbal prescription on transient cerebral global
ischemia in gerbils. J Ethnopharmacol. 2011;138(3):723–30.
47. Kim SK, Cho KO, Kim SY. The plasticity of posterior communicating artery
influences on the outcome of white matter injury induced by chronic
cerebral hypoperfusion in rats. Neurol Res. 2009;31(3):245–50.
48. Popko B, Puckett C, Lai E, Shine HD, Readhead C, Takahashi N, et al. Myelin
deficient mice: expression of myelin basic protein and generation of mice
with varying levels of myelin. Cell. 1987;48(4):713–21.
49. Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin JX, Ihara M, et al. Axonal
damage and demyelination in the white matter after chronic cerebral
hypoperfusion in the rat. Brain Res. 2002;924(1):63–70.
50. Minami M, Katayama T, Satoh M. Brain cytokines and chemokines: roles in
ischemic injury and pain. J Pharmacol Sci. 2006;100(5):461–70.
51. Banik NL. Pathogenesis of myelin breakdown in demyelinating diseases: role
of proteolytic enzymes. Crit Rev Neurobiol. 1992;6(4):257–71.
52. Chakravarty S, Herkenham M. Toll-like receptor 4 on nonhematopoietic cells
sustains CNS inflammation during endotoxemia, independent of systemic
cytokines. J Neurosci. 2005;25(7):1788–96.
53. Shinya K, Ito M, Makino A, Tanaka M, Miyake K, Eisfeld AJ, et al. The TLR4-
TRIF pathway protects against H5N1 influenza virus infection. J Virol.
2012;86(1):19–24.
54. Cao CX, Yang QW, Lv FL, Cui J, Fu HB, Wang JZ. Reduced cerebral ischemia-
reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys
Res Commun. 2007;353(2):509–14.
55. Kim DH, Jeon SJ, Jung JW, Lee S, Yoon BH, Shin BY, et al. Tanshinone
congeners improve memory impairments induced by scopolamine on
passive avoidance tasks in mice. Eur J Pharmacol. 2007;574(2):140–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kim et al. BMC Complementary and Alternative Medicine  (2015) 15:415 Page 10 of 10
